Data / Form D filings / Io Therapeutics, Inc.
Io Therapeutics, Inc.: Form D filings
Io Therapeutics, Inc., a biotechnology company in Spring, TX, filed 3 Form D notices with the SEC between 2014 and 2023. The latest, on August 3, 2023, reports $4.2 million sold of a $4.2 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9450 PINECROFT DR., SUITE 9497, Spring, TX, 77387
- Phone
- (832) 260-6201
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Texas
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1538762
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 3, 2023 | Amendment | $4,158,000 | $4,158,000 | 19 | Feb 28, 2023 | sec.gov | |
| Mar 9, 2023 | New notice | $4,158,000 | $4,158,000 | 19 | Feb 28, 2023 | sec.gov | |
| Jan 2, 2014 | New notice | $1,000,000 | $443,501 | $556,499 | 4 | Dec 20, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sharon Lew | Executive Officer | |
| Sahani Chandraratna | Director | |
| Vidyasagar Vuligonda | Executive Officer | |
| Martin Sanders | Executive Officer |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Jul 31, 2023 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Io Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.